Home Conference Coverage

Conference Coverage

Icosapent Ethyl Reduces First, Repeat, and Total Cardiovascular Events

Icosapent Ethyl Reduces First, Repeat, and Total Cardiovascular Events

Switching to Oral Antibiotic Noninferior to Intravenous for Endocarditis

Switching to Oral Antibiotic Noninferior to Intravenous Antibiotic for Infective Endocarditis

Aspirin Cessation at 90 Days Not Linked with Mortality Risk Increase

90-day Post-Stenting Aspirin Cessation Not Linked with Mortality Risk Increase

generic drugs

CLEAR Wisdom: Bempedoic Acid Linked with Reduced LDL Levels as Statin Add-on

CREOLE Study: Drug Combos with Amlodipine Reduce Hypertension in sub-Saharan African Patients

Drug Combos with Amlodipine Reduce Hypertension in sub-Saharan African Patients: CREOLE Study

risk of cardiovascular mortality

New Prevention Guidelines Emphasize Lifestyle Changes, Discourage Daily Aspirin

Apixaban Plus P2Y12 Inhibitor and No Aspirin Safe in Two Patient Groups

Apixaban Plus Clopidogrel and No Aspirin Safe in Two Patient Groups

TAVR as Good as Surgery for Low-surgical-risk Patients

TAVR as Good as Surgery for Low-surgical-risk Patients

TAVR Associated with Significant Reduction in One-year Death, Stroke

PARTNER 3: TAVR Associated with Significant Reduction in One-year Death, Stroke

Enalapril Sacubitril/Valsartan Combo Improves Outcomes in HFrEF

PIONEER-HF Analysis: Sacubitril/Valsartan Improves Outcomes in HFrEF

123...30Page 1 of 30
Advertisement

#Trending in

© 2018 by DocWise LLC. All material on this website is protected by copyright. This website also contains material copyrighted by 3rd parties.
670 Madison Ave. Manalapan, NJ 07726
732-490-5530
click me